Aphria Completes Acquisition Of German Pharmaceutical & Medical Cannabis Distributor CC Pharma

Flag_of_Canada_and_Germany.svg

CANADA: Aphria Inc. announced that it had completed its acquisition of CC Pharma GmbH, a leading distributor of pharmaceutical products, including medical cannabis, to more than 13,000 pharmacies in Germany, as well as throughout Europe. The Company continues to strengthen its end-to-end cannabis operations and infrastructure in Germany. “As one of the most promising medical cannabis Read the full article…

Greater Cannabis Company Inks Distribution Agreement With iCAN: Israel Cannabis

Greater Cannabis Company

ISRAEL: The Greater Cannabis Company, a biopharmaceutical company focused on development and commercialization of innovative delivery systems for the Cannabis market, has entered into a letter of intent with iCAN Cannabis  to expand distribution of its eluting patch platform into key global markets. The eluting patch platform is an innovative delivery system, which uses a patented Read the full article…

Aphria’s Colombian Subsidiary, Colcanna, Inks Exclusive Agreement With Colombian Medical Federation

1280px-Flag_of_Colombia.svg

CANADA:  Aphria announced that its Colombian subsidiary has signed an exclusive agreement with the Federación Médica Colombiana, a national guild that oversees the ethical exercise of the medical profession in Colombia, to jointly develop an academic curriculum on the medicinal use of cannabis. “Education in the medical community is critical for sustaining the advancement of medical cannabis in Colombia” Read the full article…

New Report: Legal Cannabis Market Projected To Grow 27% CAGR By 2023

global-economic-developing

IRELAND: The legal cannabis market is projected to register a CAGR of over 27% by 2023, according to “Global Legal Cannabis Market 2019-2023″ a new report just added to ResearchAndMarkets.com. The latest trend gaining momentum in the market is the use of advanced techniques in cannabis cultivation. According to the report, one of the major drivers for this market Read the full article…

MJNews Exclusive Interview With Saul Kaye, CEO/Founder iCAN: Israel Cannabis

Saul Kaye, iCan

Since the 1960s, Israel has led the world in medical cannabis research. Now, as international markets emerge for legal medical cannabis, the country is poised to become a major global player.  Recently, the Israeli Parliament caused a great deal of industry excitement when it passed a bill that would pave the way for Israel to become an exporter of both Read the full article…

Aphria Responds To Unsolicited Proposal By Green Growth Brands

aphria logo

CANADA: Aphria responds to the unsolicited proposal by Xanthic Biopharma d.b.a. Green Growth Brands to acquire all of the Company’s outstanding common shares in an all-stock transaction. Based on the 20-day volume weighted average price of GGB shares and the expressed exchange ratio of 1.5714 common shares of GGB for each Aphria share, the proposed bid would be Read the full article…

Canada’s Largest Cannabis Producer Brings Down CBD Oil Costs By 96.34%

ceo-of-instadose-pharma-grant-sanders-meeting-with-the-vice-minister-of-agriculture-of-the-democratic-republic-of-the-congo-drc

CANADA: Flying under the radar for the past few months, Instadose Pharma is ready to hit the market with 2 million liters of CBD oil in 2019. InstaDose Pharma has over 200,000 farmers harvesting cannabis out of the Democratic Republic of the Congo on over 100,000 hectares of land. The main production facility is GMP certified and Read the full article…

iCAN: Israel Cannabis CEO: “Cannabis to Become as Important to Israel’s Economy as High-Tech”

israel-flag-iflag-WKFrGh

ISRAEL: In a long-awaited move, the Knesset, Israel’s Parliament, has finally approved the export of medical cannabis allowing Israel to fully participate in the exploding cannabis industry world-wide. Saul Kaye, CEO of iCAN: Israel-Cannabis issued the following statement: “This is a long overdue but welcome development.  iCAN has been diligently working together with Israeli regulators to further the growth of the cannabis industry Read the full article…

FSD Pharma Announces Strategic Investment In Toronto’s Huge Shops

toronto

FSD Pharma Announces Strategic Investment in Huge Shops CANADA: FSD Pharma has completed a strategic investment of $1.3 million or just under 9.9% in Huge Shops, a Toronto-based cannabis retailer. Huge Shops has a strategic alliance with Chairman’s Brands, parent company of Coffee Time, a well-established operator of retail coffee shops with more than 75 locations in Read the full article…

AB InBev And Tilray Announce Research Partnership Focused On Non-Alcohol THC And CBD Beverages

Tilray AB InBev

New Partnership to Focus on Research that will Guide Responsible Innovation CANADA: AB InBev, the world’s leading brewer, and Tilray, a global pioneer in cannabis production and distribution, announced a partnership to research non-alcohol beverages containing tetrahydrocannabinol (THC) and cannabidiol (CBD). The partnership is limited to Canada and decisions regarding the commercialization of the beverages will Read the full article…